Automatic Web Traffic Generator

TapImmune, Inc. (TPIV) CEO Peter Hoang on the Proposed Merger with Marker Therapeutics Transcript

When we think about cell therapies today, you all know that cell therapies are captured in enormous amount of market ... first dosed patients at Baylor College of Medicine using this therapy back in 2... read more

The Immune System Fights Back

The first inkling came ... so-called exhaustion markers on T cells to understand what they mean for the potency of a cell-based immunotherapy. While companies sort out the nuances of bringing CARTs fo... read more

The Bellicum Story: What you Need to Know Going Into ASH 2015

First, there is the T cell replete HSCT where the patient is given the ... all with over 90 days of follow-up. What Does this Mean for BPX-501 vs. Gene Therapy for Orphan Blood Disorders? The Company’ ... read more

NNDA to feature county leaders at Jan. 23 Business Edge talk in Carson City

The Nevada Wolf Pack overcame another sluggish first half and improved their record ... CARSON CITY — The 3rd & Curry Street Farmers Market is kicking off 2019 with some new and exciting ... read more

R3 Stem Cell Training Course Now Offering Providers a Complimentary Procedure

In addition to providing a first rate education on stem cell therapy, the R3 Stem Cell Training Course is now offering all attendees a complimentary regenerative procedure. This is great because provi... read more

Will Personalized Medicine Mean Higher Costs for Consumers?

In the employer market, increasing pressures to cut labor costs ... of-pocket drug costs and limits on insurers’ ability to use prior authorization and step therapy requirements to create barriers to ... read more

Top Trends in Biopharmaceutical Manufacturing: 2015

New cell-culture techniques, biomanufacturing formats, biological products, and the expansion of single-use applications are driving rapid change in the biopharmaceutical market ... Monge stresses. Th... read more

Scientists Describe Five Phases of Quarter-Life Crisis, Recommend the Experience

Are you ready take a time out to find yourself, and start over? Are you 25? It may be your quarter-life crisis knocking, say psychologists studying the phenomenon of 25–35-year-olds having a come-to-J... read more

CytoDyn And HIV Therapy: CCR5 Antagonist Is An Old Drug Made New

HIV/AIDS is associated with the loss of CD4(+) T cells ... for HIV therapy. In my humble opinion, the breakthrough really began with the discovery of CCR5 and CCXR4 as portals for HIV infection. A sub... read more

Did an Experimental Stem-Cell Treatment Save Gordie Howe, or Is That Just What His Family Wants to Believe?

But around Thanksgiving, as he began refusing to do his physical therapy ... It was the first time any of the Howes had seen such a spark. She sent a video to Murray and said, “You want to call them s... read more

Acting Carson City library director to be Democratic luncheon speaker

The Nevada Wolf Pack overcame another sluggish first half and improved their record ... CARSON CITY — The 3rd & Curry Street Farmers Market is kicking off 2019 with some new and exciting ... read more

Global Parkinsons Disease Drugs Market Outlook 2022

Furthermore, the recent approval of novel Parkinson's disease drugs, which includes generic versions and first ever ... Hence, stem cell therapy presents great opportunities for the growth of global P... read more